Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03289962
Title A Study of RO7198457 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Genentech, Inc.
Indications

lung non-small cell carcinoma

melanoma

colorectal cancer

Advanced Solid Tumor

triple-receptor negative breast cancer

transitional cell carcinoma

renal cell carcinoma

head and neck squamous cell carcinoma

Therapies

RO7198457

Atezolizumab + RO7198457

Age Groups: adult | senior
Covered Countries USA | ESP | DEU | CAN | BEL

Facility Status City State Zip Country Details
HonorHealth Research Institute - Bisgrove Scottsdale Arizona 85258 United States Details
The Los Angeles Clinic Los Angeles California 90025 United States Details
UCSF Comprehensive Cancer Ctr San Francisco California 94158 United States Details
Stanford Cancer Center Stanford California 94305-5820 United States Details
University of Colorado Aurora Colorado 80045-2517 United States Details
Yale University Cancer Center, Smilow Cancer Hospital; Medical Oncology New Haven Connecticut 06511 United States Details
Georgetown University Washington District of Columbia 20007 United States Details
Massachusetts General Hospital. Boston Massachusetts 02114 United States Details
Dana Farber Can Ins Boston Massachusetts 02215 United States Details
Comprehensive Cancer Centers of Nevada (CCCN) - Central Valley Las Vegas Nevada 89169 United States Details
Columbia University Medical Center; Clinical Research Management Office New York New York 10032 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104 United States Details
Providence Oncology and Hematology Care Eastside Portland Oregon 97213 United States Details
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213 United States Details
Sarah Cannon Res Inst; TN Onc Nashville Tennessee 37203 United States Details
Seattle Cancer Care Alliance Seattle Washington 98109 United States Details
UZ Gent Gent 9000 Belgium Details
CHU Sart-Tilman Liège 4000 Belgium Details
Sint Augustinus Wilrijk Wilrijk 2610 Belgium Details
The Ottawa Hospital Cancer Centre; Oncology Ottawa Ontario K1H 8L6 Canada Details
Princess Margaret Cancer Center Toronto Ontario M5G 2M9 Canada Details
Universitätsklinikum Essen; Innere Klinik und Poliklinik für Tumorforschung Essen 45122 Germany Details
LungenClinic Großhansdorf GmbH Großhansdorf 22927 Germany Details
Nationales Centrum für Tumorerkrankungen Heidelberg (NCT); Thoraxklinik Heidelberg Heidelberg 69120 Germany Details
Fachklinik für Lungenerkrankungen Immenhausen 34376 Germany Details
Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz Mainz 55101 Germany Details
Antoni van Leeuwenhoek Ziekenhuis Amsterdam 1066 CX Netherlands Details
LUMC Leiden 2333 ZA Netherlands Details
Universitair Medisch Centrum Utrecht Utrecht 3584 CX Netherlands Details
Clinica Universitaria de Navarra; Servicio de oncología Pamplona Navarra 31008 Spain Details
Vall d´Hebron Institute of Oncology (VHIO), Barcelona Barcelona 08035 Spain Details
Karolinska Hospital; Oncology - Radiumhemmet Stockholm 171 76 Sweden Details
Akademiska sjukhuset, Onkologkliniken Uppsala 751 85 Sweden Details
Barts & London School of Med; Medical Oncology London EC1A 7BE United Kingdom Details
Southampton General Hospital; Medical Oncology Southampton SO16 6YD United Kingdom Details
The Royal Marsden Hospital Sutton SM2 5PT United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field